ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

Cancer Prevention Month: The Importance of Genetic Testing and Early Patient-Provider Conversations

February 20, 2025

Author(s):

Rachel Morrison Brown

In recognition of February as National Cancer Prevention Month, ACCC shares strategies to reduce the risk of cancer, including prioritizing genetic testing and early conversations with a health care provider.

Cancer Prevention Month: The Importance of Genetic Testing and Early Patient-Provider Conversations

February is National Cancer Prevention Month, a time to raise awareness about strategies to reduce the risk of cancer and empower people to make more informed decisions about their health. One of the most significant—and sometimes overlooked—ways to prevent cancer is by understanding one’s genetic risk. Genetic testing, paired with open and early conversations with a health care provider, can play a crucial role in identifying potential risks before they become critical.

Family History Matters

Family history is one of the most influential factors in determining an individual’s risk for certain types of cancer. Several cancers, including breast, ovarian, uterine, and colorectal cancer, have genetic links that are passed down through families. In addition, recent advancements in the genetics of prostate cancer have shown the presence of germline mutations associated with a higher risk of developing prostate cancer. ACCC has launched an educational initiative to identify practice gaps related to germline and somatic testing for hereditary mutations in metastatic prostate cancer.

Benefits of Genetic Testing

Genetic testing can be a game changer in identifying individuals at a higher risk of developing cancer. Genetic tests detect mutations in specific genes that can predispose people to certain types of cancer, allowing them to make early, proactive decisions about their health, such as:

  • Increased screening: More frequent or earlier screenings, like mammograms, colonoscopies, or MRIs, can catch cancer at its earliest and most treatable stages.
  • Preventative measures: In some cases, genetic testing can help providers recommend preventive actions, such as medications or prophylactic surgeries for those at extremely high risk.
  • Personalized treatment plans: Certified genetic counselors can give personalized medical recommendations for managing elevated cancer risks based on test results and family history.

In many cases, genetic testing is recommended for individuals with a strong family history of cancer. However, as genetic testing becomes more widely available and accessible, even those with no family history may consider testing for reassurance or as part of a wellness strategy.

Early Conversations With a Health Care Provider

Open and honest communication with a health care provider is essential in assessing one’s risk of cancer. For individuals who have a family history of cancer, it is important to bring this information up during routine visits. Ideally, this conversation should take place early on—before any signs or symptoms appear.

Engaging in this dialogue early on can reduce patients’ fear and anxiety by determining a plan of action before the threat of a cancer diagnosis looms. The proactive decision to order genetic testing based on family history and the creation of a prevention plan greatly improves patient outcomes as well.

Utilizing Genetic Counseling

Genetic counselors specialize in interpreting genetic test results and discussing the implications with patients, making them essential members of the cancer care team. Genetic counselors can help patients understand their cancer diagnosis, interpret what their results mean, make informed treatment decisions, and navigate the financial cost of testing. If necessary, they may also help facilitate genetic testing for other at-risk family members and refer patients to financial advocates or patient assistance resources.

Cancer Prevention Month is a reminder that taking charge of your health can significantly lower your cancer risk. By understanding your genetic predispositions and having proactive conversations with your health care provider, you are setting the foundation for a healthier future. Early detection, prevention, and personalized care can make all the difference in the fight against cancer.

Related Content

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

A Leadership Playbook for Responsible AI AdoptionACCCBuzz Blog

A Leadership Playbook for Responsible AI Adoption

June 4, 2026

Health Literacy in the Digital Age: An NCCN Policy SummitACCCBuzz Blog

Health Literacy in the Digital Age: An NCCN Policy Summit

Gabrielle Stearns

June 2, 2026

Turning Innovation Into Access: A Conversation With ACCC’s Executive DirectorACCCBuzz Blog

Turning Innovation Into Access: A Conversation With ACCC’s Executive Director

Rachel Radwan

May 27, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
MSOS 2026 Great Falls Meeting
Breast Cancer

MSOS 2026 Great Falls Meeting

In Person Conference & ConventionJune 25, 2026 at 5:30 PM MDT1117 29th St S, Great Falls, MT, USAGuy Tobacco Room, Benefis Cancer Center, Great Falls
Register Now!
COS 2026 Dinner at the Denver Best of ASCO
Oncology

COS 2026 Dinner at the Denver Best of ASCO

In Person Meeting & NetworkingJune 26, 2026 at 5:30 PM MDT7000 Church Ranch Blvd, Westminster, CO, USADenver Marriott Westminster, Westminster
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Each year, the NCCN State Oncology Society Forum is thoughtfully organized to foster meaningful collaboration and forge common bonds to advance dignity and fair access to cancer care. In this blog, Sean T. McCarson shares key insights from stakeholders across the oncology policy landscape at this year's meeting.

Highlights from Volume 41, Number 3 Oncology Issues

Highlights from Volume 41, Number 3 Oncology Issues

The latest issue of Oncology Issues features key insights from the inaugural ACCC Leadership Summit, strategies to adjust to rising patient volumes and workforce strain, advanced practice leadership models, and more.

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

In the third in a series of multidisciplinary consensus-building roundtables, ACCC and its partners explored ways to bridge the gap between community oncology programs and authorized treatment centers offering CAR T for patients with multiple myeloma.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Data-Driven Toxicity Management for ADCs – [Video Podcast] Ep. 235

Advancing Cancer Care Worldwide: ACCC Global eXchange - [Mini Podcast] Ep. 234

Designing Care That Creates Value for Patients and the Health System - [Mini Podcast] Ep. 233

A Collaborative Approach to Health Policy Changes - [Mini Podcast] Ep. 232

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login